当前位置:首页 - 行情中心 - 山东药玻(600529) - 财务分析

山东药玻

(600529)

  

流通市值:121.51亿  总市值:121.51亿
流通股本:6.64亿   总股本:6.64亿

山东药玻(600529)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润2.01亿元,每股收益0.30元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益837634.40万元,未分配利润428464.96万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1013662.80万元,负债176028.40万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,219,063,985.044,474,018,978.753,352,070,071.232,250,208,818.82
营业总成本960,424,944.763,533,710,798.92,658,703,139.691,777,978,175.35
其他经营收益
营业利润241,794,104.58837,960,826.94651,866,577.9444,092,441.69
利润总额239,229,487.78830,828,068.79648,391,295.8441,547,642.49
净利润201,206,020.13689,626,040.66542,453,658.37371,141,622
每股收益
其他综合收益----
综合收益总额201,206,020.13689,626,040.66542,453,658.37371,141,622
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计6,106,789,974.146,012,161,093.165,796,596,188.315,906,627,859.56
非流动资产:
非流动资产合计4,029,838,028.84,031,608,632.224,085,758,516.844,068,834,718.96
资产总计10,136,628,002.9410,043,769,725.389,882,354,705.159,975,462,578.52
流动负债:
流动负债合计1,611,972,910.41,601,199,646.031,605,866,076.131,680,931,466.04
非流动负债:
非流动负债合计148,311,102.72147,927,922.87127,414,007.84129,989,449
负债合计1,760,284,013.121,749,127,568.91,733,280,083.971,810,920,915.04
所有者权益(或股东权益):
归属于母公司股东权益合计8,376,343,989.828,294,642,156.488,149,074,621.188,164,541,663.48
股东权益合计8,376,343,989.828,294,642,156.488,149,074,621.188,164,541,663.48
负债和股东权益合计10,136,628,002.9410,043,769,725.389,882,354,705.159,975,462,578.52
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,144,890,161.954,555,263,360.654,029,175,063.032,655,036,091.17
经营活动现金流出小计931,900,710.733,978,338,397.293,518,218,534.812,355,595,344.52
经营活动产生的现金流量净额212,989,451.22576,924,963.36510,956,528.22299,440,746.65
投资活动产生的现金流量:
投资活动现金流入小计2,295,990,305.848,023,272,106.766,156,698,640.544,387,693,186.49
投资活动现金流出小计1,031,041,960.348,171,864,537.196,515,042,423.884,573,845,660.91
投资活动产生的现金流量净额1,264,948,345.5-148,592,430.43-358,343,783.34-186,152,474.42
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计2,079,383.31376,750,003.57370,341,793.4180,554,602.56
筹资活动产生的现金流量净额-2,079,383.31-376,750,003.57-370,341,793.4-180,554,602.56
汇率变动对现金及现金等价物的影响-5,991,709.375,793,613.617,322,055.647,833,614.04
现金及现金等价物净增加额1,469,866,704.0457,376,142.97-210,406,992.88-59,432,716.29
期末现金及现金等价物余额2,412,424,208.72942,557,504.68674,774,368.83825,748,645.42
补充资料:
现金及现金等价物的净增加额-57,376,142.97--59,432,716.29
最新报告期:2026-05-03
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
国联民生武慧东1.201.371.542026-05-03
长江证券李浩,范超1.221.361.502026-04-30
长江证券李浩,范超1.221.361.502026-03-25
西南证券陈辰,杜向阳1.221.291.412026-03-16
申万宏源任杰,宋涛,郝子禹1.161.261.392026-03-11
TOP↑